Reaction
Rash Follicular reporting signals
As of the last recalculation, Rash Follicular appears in 154 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 120.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vemurafenib | 10 | 120.2 | 120.3 |
| Panitumumab | 8 | 72.8 | 72.8 |